What’s New from the 2016 ESMO Clinical Guidelines

New Findings in Malignant Pleural Mesothelioma (MPM)

Today’s Age of Drug Development Q & A with Kapil Dhingra, MD

Next-Generation Sequencing Across the World: Reports from France, Germany, and China

Update to the “Molecular Testing Guideline for Selection of Lung Cancer Patients for EGFR and ALK Tyrosine Kinase Inhibitors”

Genetic Differences in Lung Cancers Arising in Smokers and Never-Smokers

Roswell Park Cancer Institute to Conduct First CimaVax Trial in the United States

National Comprehensive Cancer Network NSCLC Guideline Updates for 2016: Non-Small Cell Lung Cancer

Multifaceted Initiative Launches Aimed at Reducing Lung Cancer Deaths 25% by 2030

COVID-19 and Lung Cancer

The Art and Science of Patient–Doctor Communication

In Brief for February 9, 2022